Valuation: Bausch Health Companies Inc.

Market Cap 178.52Cr 156.15Cr 144.03Cr 133.03Cr 252.41Cr 17TCr 256.66Cr 1.72TCr 675.81Cr 8.39TCr 670.29Cr 655.71Cr 29TCr P/E 2026 *
-10.7x
P/E 2027 * 2.9x
Enterprise Value 178.52Cr 156.15Cr 144.03Cr 133.03Cr 252.41Cr 17TCr 256.66Cr 1.72TCr 675.81Cr 8.39TCr 670.29Cr 655.71Cr 29TCr EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.17x
Free-Float
87.38%
Yield 2026 *
-
Yield 2027 * -
1 day-1.65%
1 week-2.45%
Current month-3.04%
1 month-7.36%
3 months-14.64%
6 months-35.49%
Current year-31.22%
1 week 4.7
Extreme 4.7
5
1 month 4.56
Extreme 4.565
5.94
Current year 4.56
Extreme 4.565
8
1 year 4.56
Extreme 4.565
8.68
3 years 3.96
Extreme 3.96
11.46
5 years 3.96
Extreme 3.96
30.01
10 years 3.96
Extreme 3.96
34.8
Manager TitleAgeSince
Chief Executive Officer 64 10/05/2022
Director of Finance/CFO 60 19/08/2024
Chief Tech/Sci/R&D Officer - 02/12/2024
Director TitleAgeSince
Chairman 69 10/05/2022
Director/Board Member 64 10/05/2022
Director/Board Member 56 14/06/2016
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

6,845 0.0018%
30/06Free

Chairman

12,677 0.0034%
30/06Free

Director

1,394 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-2.45%-25.55%-44.74% 178.52Cr
-2.33%-2.09%+49.88%+170.51% 1,06000Cr
-0.82%-2.30%+63.79%+62.00% 62TCr
-0.73%-4.98%+28.91%+82.99% 44TCr
+0.33%-1.17%+31.07%+27.09% 33TCr
-0.02%-2.85%+29.15%+45.24% 28TCr
-3.89%-11.22%+22.81%+27.30% 27TCr
+0.66%-1.42%-26.59%-37.71% 22TCr
-0.06%-2.88%+23.07%+62.33% 20TCr
-3.72%-1.10%+18.41%+70.56% 16TCr
Average -1.22%-3.00%+21.50%+46.56% 35.76TCr
Weighted average by Cap. -1.32%-2.96%+36.72%+83.84%

Financials

2026 *2027 *
Net sales 1.07TCr 939.87Cr 866.91Cr 800.68Cr 1.52TCr 1,02500Cr 1.54TCr 10TCr 4.07TCr 50TCr 4.03TCr 3.95TCr 1,73600Cr 1.07TCr 939.44Cr 866.52Cr 800.31Cr 1.52TCr 1,02400Cr 1.54TCr 10TCr 4.07TCr 50TCr 4.03TCr 3.94TCr 1,73500Cr
Net income -16Cr -14Cr -13Cr -12Cr -23Cr -1.55TCr -23Cr -157.13Cr -62Cr -765.84Cr -61Cr -60Cr -2.63TCr 62Cr 54Cr 50Cr 46Cr 88Cr 5.92TCr 89Cr 598.15Cr 234.9Cr 2.92TCr 232.98Cr 227.91Cr 10TCr
Net Debt - -
Logo Bausch Health Companies Inc.
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Employees
20,300
Date Price Change Volume
10/26/10 $4.780 -1.65% 13,67,254
09/26/09 $4.860 -1.02% 15,51,222
08/26/08 $4.910 0.00% 12,09,561
07/26/07 $4.910 +2.08% 19,91,298
06/26/06 $4.810 -1.84% 27,73,842
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
4.780USD
Average target price
7.400USD
Spread / Average Target
+54.81%

Quarterly revenue - Rate of surprise